Number of patients | 26 |
Neurologic involvement [n (%)] | |
CNS involvement | 26 (100.0%) |
PNS involvement | 4 (15.4%) |
Neurologic involvement as initial manifestation | 4 (15.4%) |
Neurologic manifestations of CNS involvement [n (%)] | |
Headache | 26 (100.0%) |
Cranial nerve palsy | 16 (61.5%) |
Multiple CN involvement | |
CN I | 0 (0%) |
CN II | 7 (26.9%) |
CN III | 3 (11.5%) |
CN IV | 2 (7.7%) |
CN V | 6 (23.1%) |
CN VI | 3 (11.5%) |
CN VII | 7 (26.9%) |
CN VIII | 5 (19.2%) |
CN IX | 2 (7.7%) |
CN X | 2 (7.7%) |
CN XI | 0 (0%) |
CN XII | 2 (7.7%) |
Pituitary involvement | 4 (15.4%) |
Neuroimaging findings indicating HCP | 26 (100.0%) |
Diffuse HCP | 22 (84.6%) |
Sites of HCP involvement [n (%)] | |
Falx | 5 (19.2%) |
Convexity | 12 (46.2%) |
Tentorium | 9 (34.6%) |
Skull base | 11 (42.3%) |
Sellar region | 2 (7.7%) |
CSF pressurea[mmH2O], median (IQR) | 155 (125, 185) |
CSF proteinb[mg/dL], median (IQR) | 49 (34.75, 65.25) |
CSF WBC countb[leukocytes/mm3], median (IQR) | 2 (0, 6.75) |